ArticleCancer discovery2025

Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.

Sriram Venneti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.